Valbiotis   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: La Rochelle France (2014)

Organization Overview

First Clinical Trial
2016
NCT02868177
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Valbiotis